IDSA Foundation, in collaboration with Johnson & Johnson Innovation – JLABS will host the 2021 IDea Incubator, the premier showcase of technology in the field of infectious diseases and a pitch-style competition that drives innovations across various disciplines with the potential to improve the infectious diseases specialty and patient care.
In separate United Kingdom meetings June 3-5, G7 ministers of health and finance committed their nations to confronting the growing threat of antimicrobial resistance, with meaningful and concrete actions. The concluding documents from the ministers’ meetings directly address priorities promoted by the Infectious Diseases Society of America. With commitments to foster new antibiotic development through international and cross-sectoral collaboration
With significant increases and meaningful investments in U.S. Centers for Disease Control and State Department global health programs, President Biden’s proposed budget for the coming fiscal year offers the promise of renewing our country’s role as a leader of infectious disease responses that can detect, prevent and contain public health threats where they emerge.
The U.S. Centers for Disease Control and Prevention recommendations that fully immunized people can resume most daily activities without masks or concern for physical distancing, except where required by laws and policies, reflect the remarkable protective benefit of COVID-19 vaccines.
More than 60 Congressional representatives from both sides of the aisle have called on House appropriators to significantly increase federal resources in the year ahead to tackle the growing crisis of infections that do not respond to available treatments.
The Biden Administration’s pledge of medical aid for India to combat the country’s surge of COVID-19 shows an important commitment to tackling the pandemic as a shared crisis. We commend the Administration for taking this step and for its plans to share up to 60 million doses of the AstraZeneca vaccine.
“Today’s announcement by FDA and CDC to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine is an indication that our safety monitoring system is working." Read More.
President Biden’s first proposed budget plan released today sends an encouraging message of intent to strengthen our nation’s health infrastructure, renew our standing as global leaders against infectious diseases and make our powerful resources equitably accessible to all Americans.
The HIV Medicine Association and the Infectious Diseases Society of America applaud the introduction of legislation on Friday by Rep. Lisa Blunt Rochester (D-AL) to address the critical shortage of clinicians and dentists caring for people with HIV
In response to member feedback, IDSA has launched a print opt-out option for all members that receive biweekly issues of The Journal of Infectious Diseases in hard copy. Members that prefer not to receive JID in print may now receive their regular issues in electronic-only format.
While COVID-19 has taken the place of tuberculosis as the world’s leading infectious disease killer, on this World TB Day the ancient disease remains our oldest and most neglected epidemic despite being preventable and curable.
A coalition of organizations representing clinicians, scientists, patients, public health professionals and animal agriculture experts as well as members of the pharmaceutical and diagnostics industries are asking congressional leaders to significantly increase U.S. investments